Accelerate Diagnostics, Inc. – LSE:0H8E.L

Accelerate Diagnostics stock price today

$0.515
-0.51
-49.98%
Financial Health
0
1
2
3
4
5
6
7
8
9

Accelerate Diagnostics stock price monthly change

-12.71%
month

Accelerate Diagnostics stock price quarterly change

-12.71%
quarter

Accelerate Diagnostics stock price yearly change

-75.94%
year

Accelerate Diagnostics key metrics

Market Cap
 29.80M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -4.53
Revenue
 12.16M
EBITDA
 -44.81M
Income
 -59.05M
Revenue Q/Q
 3.87%
Revenue Y/Y
 -3.46%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 -368.27%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Accelerate Diagnostics stock price history

Accelerate Diagnostics stock forecast

Accelerate Diagnostics financial statements

Profit Margin

Accelerate Diagnostics, Inc. (LSE:0H8E.L): Profit margin
Jun 2023 2.92M -32.73M -1120.68%
Sep 2023 3.29M 910K 27.58%
Dec 2023 3.02M -12.99M -429.4%
Mar 2024 2.92M -14.23M -487.16%
0H8E.L income statement history

Accelerate Diagnostics Financials Estimate

Accelerate Diagnostics, Inc. (LSE:0H8E.L): Analyst Estimates
Sep 2025 4.30M -4.49M -104.33%
Oct 2025 4.30M -5.86M -136.31%
Dec 2025 6.2M -4.94M -79.81%
Dec 2025 4.49M -5.75M -128.1%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Accelerate Diagnostics, Inc. (LSE:0H8E.L): Debt to assets
Jun 2023 49878000 88.54M 177.52%
Sep 2023 39324000 74.35M 189.09%
Dec 2023 31366000 51.25M 163.41%
Mar 2024 30722000 56.50M 183.91%
0H8E.L balance sheet history

Cash Flow

Accelerate Diagnostics, Inc. (LSE:0H8E.L): Cash Flow
Jun 2023 -10.82M 915K 9.80M
Sep 2023 -8.25M -354K -817K
Dec 2023 -7.75M -110K 107K
Mar 2024 -8.45M -513K 11.43M
0H8E.L cash flow history

Accelerate Diagnostics alternative data

Accelerate Diagnostics
Employees

Accelerate Diagnostics, Inc. (LSE:0H8E.L): Employee count
Aug 2023 179
Sep 2023 179
Oct 2023 179
Nov 2023 179
Dec 2023 179
Jan 2024 179
Feb 2024 179
Mar 2024 179
Apr 2024 179
May 2024 134
Jun 2024 134
Jul 2024 134

Accelerate Diagnostics other data

Frequently Asked Questions (FAQ)

  • What's the price of Accelerate Diagnostics stock today?

    One share of Accelerate Diagnostics stock can currently be purchased for approximately $0.52.

  • When is Accelerate Diagnostics's next earnings date?

    Unfortunately, Accelerate Diagnostics's (0H8E.L) next earnings date is currently unknown.

  • Does Accelerate Diagnostics pay dividends?

    No, Accelerate Diagnostics does not pay dividends.

  • How much money does Accelerate Diagnostics make?

    Accelerate Diagnostics has a market capitalization of 29.80M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 5.43% to 12.06M US dollars.

  • What is Accelerate Diagnostics's stock symbol?

    Accelerate Diagnostics, Inc. is traded on the LSE under the ticker symbol "0H8E.L".

  • What is Accelerate Diagnostics's primary industry?

    Company operates in the Healthcare sector and Medical - Specialties industry.

  • How do i buy shares of Accelerate Diagnostics?

    Shares of Accelerate Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Accelerate Diagnostics have?

    As Jul 2024, Accelerate Diagnostics employs 134 workers, which is 25% less then previous quarter.

  • When Accelerate Diagnostics went public?

    Accelerate Diagnostics, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.

  • What is Accelerate Diagnostics's official website?

    The official website for Accelerate Diagnostics is acceleratediagnostics.com.

  • Where are Accelerate Diagnostics's headquarters?

    Accelerate Diagnostics is headquartered at 3950 South Country Club Road, Tucson, AZ.

  • How can i contact Accelerate Diagnostics?

    Accelerate Diagnostics's mailing address is 3950 South Country Club Road, Tucson, AZ and company can be reached via phone at +52 03653100.

Accelerate Diagnostics company profile:

Accelerate Diagnostics, Inc.

acceleratediagnostics.com
Exchange:

LSE

Full time employees:

134

Industry:

Medical - Specialties

Sector:

Healthcare

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

+52 03653100
3950 South Country Club Road
Tucson, AZ 85714

:
ISIN: US00430H2013
CUSIP: 00430H201